 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
19 November 2002 | Volume 137 Issue 10 | Pages 834-839
This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations for use of hormone replacement therapy for the primary prevention of chronic conditions in postmenopausal women and updates the 1996 USPSTF recommendations on this topic. The complete information on which this statement is based, including evidence tables and references, is available through the USPSTF Web site (http://www.preventiveservices.ahrq.gov) and through the National Guideline Clearinghouse (http://www.guideline.gov) The USPSTF reviewed the evidence on the use of postmenopausal hormone replacement therapy and the following outcomes: cardiovascular disease, including CHD and stroke; osteoporosis and fractures; thromboembolism; dementia and cognitive function; breast, colon, ovarian, and endometrial cancer; and cholecystitis. The USPSTF also reviewed evidence of the effects of hormone replacement therapy on phytoestrogens and osteoporosis and cardiovascular disease. The use of hormone replacement therapy for relieving active symptoms of menopause, such as hot flashes, urogenital symptoms, and mood and sleep disturbances, among others, is outside the scope of these USPSTF recommendations, and literature on this topic was not reviewed. Sources for estimates of benefits and harms cited in this Recommendation statement are described in the summary of the evidence available from the Agency for Healthcare Research and Quality.
*For a list of the members of the U.S. Preventive Services Task Force, see Appendix.
Author and Article Information
From the U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland.
Requests for Single Reprints: Reprints are available from the USPSTF Web site (http://www.preventiveservices.ahrq.gov) and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (800-358-9295). CLINICAL GUIDELINES
Postmenopausal Hormone Replacement Therapy for Primary Prevention of Chronic Conditions: Recommendations and Rationale
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  S. Shantakumar, M. B. Terry, A. Paykin, S. L. Teitelbaum, J. A. Britton, P. G. Moorman, S. B. Kritchevsky, A. I. Neugut, and M. D. Gammon Age and Menopausal Effects of Hormonal Birth Control and Hormone Replacement Therapy in Relation to Breast Cancer Risk Am. J. Epidemiol., May 15, 2007; 165(10): 1187 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Codes, T. Asselah, D. Cazals-Hatem, F. Tubach, D. Vidaud, R. Parana, P. Bedossa, D. Valla, and P. Marcellin Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy Gut, March 1, 2007; 56(3): 390 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. V. Lacey Jr., L. A. Brinton, M. F. Leitzmann, T. Mouw, A. Hollenbeck, A. Schatzkin, and P. Hartge Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort. J Natl Cancer Inst, October 4, 2006; 98(19): 1397 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhang, X.-O. Shu, H. Li, G. Yang, Q. Li, Y.-T. Gao, and W. Zheng Prospective Cohort Study of Soy Food Consumption and Risk of Bone Fracture Among Postmenopausal Women Arch Intern Med, September 12, 2005; 165(16): 1890 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Eisen and D. S. Weinberg Narrative Review: Screening for Colorectal Cancer in Patients with a First-Degree Relative with Colonic Neoplasia Ann Intern Med, August 2, 2005; 143(3): 190 - 198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H.K. Vogel, S. F. Bolling, R. B. Costello, E. M. Guarneri, M. W. Krucoff, J. C. Longhurst, B. Olshansky, K. R. Pelletier, C. M. Tracy, R. A. Vogel, et al. Integrating Complementary Medicine Into Cardiovascular Medicine: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine) J. Am. Coll. Cardiol., July 5, 2005; 46(1): 184 - 221. [Full Text] [PDF]
|
|
|
|
 |
|
 D.J. Hosking, P. Geusens, and R. Rizzoli Osteoporosis therapy: an example of putting evidence-based medicine into clinical practice QJM, June 1, 2005; 98(6): 403 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Ovarian, Endometrial, and Colorectal Cancers Obstet. Gynecol., October 1, 2004; 104(4_suppl): 77S - 84S. [Full Text] [PDF]
|
|
|
|
|
|
Vasomotor Symptoms Obstet. Gynecol., October 1, 2004; 104(4_suppl): 106S - 117S. [Full Text] [PDF]
|
|
|
|
|
|
Summary of Balancing Risks and Benefits Obstet. Gynecol., October 1, 2004; 104(4_suppl): 128S - 129S. [Full Text] [PDF]
|
|
|
|
 |
|
 H. V. Lochner and T. A. Einhorn Hormone Replacement Therapy J. Am. Acad. Ortho. Surg., September 1, 2004; 12(5): 291 - 294. [Full Text] [PDF]
|
|
|
|
|
|
C. L. Roumie, E. L. Grogan, W. Falbe, J. Awad, T. Speroff, R. S. Dittus, and T. A. Elasy A Three-Part Intervention To Change the Use of Hormone Replacement Therapy in Response to New Evidence Ann Intern Med, July 20, 2004; 141(2): 118 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. H Kuller Commentary: Hazards of studying women: the oestrogen oestrogen/progesterone dilemma Int. J. Epidemiol., June 1, 2004; 33(3): 459 - 460. [Full Text] [PDF]
|
|
|
|
 |
|
 C. N. Wathen, D. S. Feig, J. W. Feightner, B. L. Abramson, and A. M. Cheung Hormone replacement therapy for the primary prevention of chronic diseases: recommendation statement from the Canadian Task Force on Preventive Health Care Can. Med. Assoc. J., May 11, 2004; 170(10): 1535 - 1537. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Armstrong, J. S. Schwartz, T. Randall, S. C. Rubin, and B. Weber Hormone Replacement Therapy and Life Expectancy After Prophylactic Oophorectomy in Women With BRCA1/2 Mutations: A Decision Analysis J. Clin. Oncol., March 15, 2004; 22(6): 1045 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Haas, C. P. Kaplan, E. P. Gerstenberger, and K. Kerlikowske Changes in the Use of Postmenopausal Hormone Therapy after the Publication of Clinical Trial Results Ann Intern Med, February 3, 2004; 140(3): 184 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Hersh, M. L. Stefanick, and R. S. Stafford National Use of Postmenopausal Hormone Therapy: Annual Trends and Response to Recent Evidence JAMA, January 7, 2004; 291(1): 47 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Neves-e-Castro Menopause in crisis post-Women's Health Initiative? A view based on personal clinical experience Hum. Reprod., December 1, 2003; 18(12): 2512 - 2518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Anderson, H. L. Judd, A. M. Kaunitz, D. H. Barad, S. A. A. Beresford, M. Pettinger, J. Liu, S. G. McNeeley, and A. M. Lopez Effects of Estrogen Plus Progestin on Gynecologic Cancers and Associated Diagnostic Procedures: The Women's Health Initiative Randomized Trial JAMA, October 1, 2003; 290(13): 1739 - 1748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Dulli Stroke Risk, Hypertension, and HRTless Postmenopausal Therapy Arch Neurol, October 1, 2003; 60(10): 1363 - 1364. [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Manson, J. Hsia, K. C. Johnson, J. E. Rossouw, A. R. Assaf, N. L. Lasser, M. Trevisan, H. R. Black, S. R. Heckbert, R. Detrano, et al. Estrogen plus Progestin and the Risk of Coronary Heart Disease N. Engl. J. Med., August 7, 2003; 349(6): 523 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Chlebowski, S. L. Hendrix, R. D. Langer, M. L. Stefanick, M. Gass, D. Lane, R. J. Rodabough, M. A. Gilligan, M. G. Cyr, C. A. Thomson, et al. Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women's Health Initiative Randomized Trial JAMA, June 25, 2003; 289(24): 3243 - 3253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hays, J. K. Ockene, R. L. Brunner, J. M. Kotchen, J. E. Manson, R. E. Patterson, A. K. Aragaki, S. A. Shumaker, R. G. Brzyski, A. Z. LaCroix, et al. Effects of Estrogen plus Progestin on Health-Related Quality of Life N. Engl. J. Med., May 8, 2003; 348(19): 1839 - 1854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Buckwalter, J. D. Heckman, and D. P. Petrie An AOA Critical Issue: Aging of the North American Population: New Challenges for Orthopaedics J. Bone Joint Surg. Am., March 31, 2003; 85(4): 748 - 758. [Full Text] [PDF]
|
|
|
|
 |
|
 Menopausal Hormone Replacement Therapy Journal Watch (General), November 22, 2002; 2002(1122): 2 - 2. [Full Text]
|
|
|
|
|
|
J. Yates, E. Barrett-Connor, S. Barlas, Y.-T. Chen, P. D. Miller, and E. S. Siris Rapid Loss of Hip Fracture Protection After Estrogen Cessation: Evidence From the National Osteoporosis Risk Assessment Obstet. Gynecol., January 1, 2000; 103(3): 440 - 446. [Abstract] [Full Text]
|
|
Article
